期刊的影响因子--文章列表

期刊文章列表
Editoral Office of Acta Pharmaceutica Sinica.Information for Authors[J].药学学报(英文版),2022,第6期 Editoral Office of Acta Pharmaceutica Sinica（Editoral Office of Acta Pharmaceutica Sinica）.Information for Authors[J].Acta Pharmaceutica Sinica B,2022,第6期 Piao Luo^1,2，Dandan Liu¹，Qian Zhang¹，Fan Yang^3,4，Yin-Kwan Wong¹，Fei Xia¹，Junzhe Zhang¹，Jiayun Chen¹，Ya Tian¹，Chuanbin Yang³，Lingyun Dai³，Han-Ming Shen⁵，Jigang Wang^1,2,3,4,6（Artemisinin Research Center，Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences；Central People's Hospital of Zhanjiang；Department of Urology，the Second Clinical Medical College，Jinan University(Shenzhen People's Hospital)；Integrated Chinese and Western Medicine Postdoctoral Research Station，Jinan University；Faculty of Health Sciences，University of Macau；Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University）.Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1[J].Acta Pharmaceutica Sinica B,2022,第5期 Baoyi Guan^1,2，Jinlin Tong¹，Haiping Hao³，Zhixu Yang¹，Keji Chen^1,2，Hao Xu^1,2，Anlu Wang^1,2（Xiyuan Hospital，China Academy of Chinese Medical Sciences；National Clinical Research Center for Chinese Medicine Cardiology；State Key Laboratory of Natural Medicines，China Pharmaceutical University）.Bile acid coordinates microbiota homeostasis and systemic immunometabolism in cardiometabolic diseases[J].Acta Pharmaceutica Sinica B,2022,第5期 Chan Feng^1,2,3，Yongjiang Li^2,4，Bijan Emiliano Ferdows²，Dylan Neal Patel²，Jiang Ouyang²，Zhongmin Tang²，Na Kong²，Enguo Chen^1,3，Wei Tao²（Department of Respiratory Medicine，Sir Run Run Shaw Hospital，Zhejiang University School of Medicine；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women's Hospital，Harvard Medical School；Cancer Center，Zhejiang University；Department of Pharmacy，the Second Xiangya Hospital of Central South University；Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Emerging vaccine nanotechnology：From defense against infection to sniping cancer[J].Acta Pharmaceutica Sinica B,2022,第5期 Xuesong Li¹，Ruigong Zhu¹，Hong Jiang¹，Quanwen Yin¹，Jiaming Gu¹，Jiajing Chen¹，Xian Ji¹，Xuan Wu¹，Haiping Fu¹，Hui Wang¹，Xin Tang¹，Yuanqing Gao¹，Bingjian Wang²，Yong Ji^1,3，Hongshan Chen^1,3,4,2（Key Laboratory of Cardiovascular and Cerebrovascular Medicine，School of Pharmacy，Nanjing Medical University；Department of Cardiology，Huai'an First People's Hospital Affiliated with Nanjing Medical University；Key Laboratory of Targeted Intervention of Cardiovascular Disease，Collaborative Innovation Center for Cardiovascular Disease Translational Medicine，Nanjing Medical University；Department of Cardiothoracic Surgery，the Second Affiliated Hospital of Nanjing Medical University）.Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis via the TFEB-P300-BRD4 axis[J].Acta Pharmaceutica Sinica B,2022,第5期 Dandan Shen^1,2，Bo Wang^1,2，Ya Gao^1,2，Lijuan Zhao^1,2,3，Yaping Bi^1,2，Jinge Zhang^1,2，Ning Wang⁴，Huiqin Kang^1,2，Jingru Pang^1,2，Ying Liu^1,2，Luping Pang^1,2，Zhe-Sheng Chen⁵，Yi-Chao Zheng^1,2,3，Hong-Min Liu^1,2,3（Key Laboratory of Advanced Drug Preparation Technologies，Ministry of Education of China，Collaborative Innovation Center of New Drug Research and Safety Evaluation，Zhengzhou University；Key Laboratory of Henan Province for Drug Quality and Evaluation，Institute of Drug Discovery and Development，School of Pharmaceutical Sciences，Zhengzhou University；State Key Laboratory of Esophageal Cancer Prevention & Treatment，Academy of Medical Sciences，Zhengzhou University；The School of Chinese Medicine，The University of Hong Kong；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University）.Detailed resume of RNA m~6A demethylases[J].Acta Pharmaceutica Sinica B,2022,第5期 Kun Luo^1,2，Wenting Huang^1,2，Liansheng Qiao^1,2，Xiaoling Zhang³，Di Yan⁴，Zhiyu Ning^1,2，Chengmei Ma³，Honglei Dang³，Dong Wang⁴，Hongyan Guo³，Lan Xie^1,2,3，Jing Cheng^1,2,3,4（State Key Laboratory of Membrane Biology，School of Medicine，Tsinghua University；Medical Systems Biology Research Center，School of Medicine，Tsinghua University；National Engineering Research Center for Beijing Biochip Technology；School of Basic Medical Sciences，Chengdu University of Traditional Chinese Medicine）.Dendrocalamus latiflorus and its component rutin exhibit glucose-lowering activities by inhibiting hepatic glucose production via AKT activation[J].Acta Pharmaceutica Sinica B,2022,第5期 Wufa Fan¹，Haixia Peng¹，Zhou Yu¹，Luting Wang¹，Haisheng He¹，Yuhua Ma^1,2，Jianping Qi^1,3，Yi Lu^1,3，Wei Wu^1,4,3（Key Laboratory of Smart Drug Delivery of MOE，School of Pharmacy，Fudan University；Key Laboratory for Tibet Plateau Phytochemistry of Qinghai Province，School of Pharmacy，Qinghai Nationalities University；Shanghai Skin Disease Hospital，Tongji University School of Medicine；Center for Medical Research and Innovation，Shanghai Pudong Hospital，Fudan University Pudong Medical Center）.The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers[J].Acta Pharmaceutica Sinica B,2022,第5期 Yuhong Zhang¹，Yanqing Ding¹，Min Li¹，Jing Yuan²，Youhui Yu²，Xueying Bi¹，Huiqi Hong¹，Jiantao Ye¹，Peiqing Liu¹（Department of Pharmacology and Toxicology，School of Pharmaceutical Sciences，National and Local United Engineering Lab of Druggability and New Drugs Evaluation，Sun Yat-sen University；State Key Laboratory of Oncology in Southern China，Collaborative Innovation Center for Cancer Medicine，Sun Yat-sen University Cancer Center）.MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B[J].Acta Pharmaceutica Sinica B,2022,第5期 Qiuyi Li，Cheng Chen，Jinxia Kong，Lian Li，Junlin Li，Yuan Huang（Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province，Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology，West China School of Pharmacy，Sichuan University）.Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade[J].Acta Pharmaceutica Sinica B,2022,第5期 Xiaoli Pan¹，Junping Pei¹，Aoxue Wang¹，Wen Shuai¹，Lu Feng¹，Faqian Bu¹，Yumeng Zhu¹，Lan Zhang²，Guan Wang¹，Liang Ouyang¹（State Key Laboratory of Biotherapy and Cancer Center，Innovation Center of Nursing Research，Nursing Key Laboratory of Sichuan Province，National Clinical Research Center for Geriatrics，West China Hospital，and Collaborative Innovation Center of Biotherapy，Sichuan University；Sichuan Engineering Research Center for Biomimetic Synthesis of Natural Drugs，School of Life Science and Engineering，Southwest Jiaotong University）.Development of small molecule extracellular signal-regulated kinases（ERKs） inhibitors for cancer therapy[J].Acta Pharmaceutica Sinica B,2022,第5期 Xiaoling Chen¹，Jingliang Zhang¹，KeWei Wang²（Department of Molecular and Cellular Pharmacology，State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，Qingdao University School of Pharmacy）.Inhibition of intracellular proton-sensitive Ca²⁺-permeable TRPV3 channels protects against ischemic brain injury[J].Acta Pharmaceutica Sinica B,2022,第5期 Sifan Yu^1,2，Dijie Li^1,2,3，Ning Zhang⁴，Shuaijian Ni^1,2,3，Meiheng Sun^1,2,3，Luyao Wang^1,2,3，Huan Xiao⁴，Dingdong Liu^1,2,3，Jin Liu^1,2,3，Yuanyuan Yu^1,2,3，Zongkang Zhang⁴，Samuel Tin Yui Yeung¹，Shu Zhang⁵，Aiping Lu^1,2,3，Zhenlin Zhang⁶，Baoting Zhang⁴，Ge Zhang^1,2,3（Law Sau Fai Institute for Advancing Translational Medicine in Bone and Joint Diseases，School of Chinese Medicine，Hong Kong Baptist University；Institute of Integrated Bioinfomedicine and Translational Science，School of Chinese Medicine，Hong Kong Baptist University；Institute of Precision Medicine and Innovative Drug Discovery，HKBU Institute for Research and Continuing Education；School of Chinese Medicine，Faculty of Medicine，the Chinese University of Hong Kong；The Key Laboratory of Aerospace Medicine，Ministry of Education，Air Force Medical University；Shanghai Clinical Research Center of Bone Disease，Department of Osteoporosis and Bone Diseases，Shanghai Jiao Tong University Affiliated Sixth People's Hospital）.Drug discovery of sclerostin inhibitors[J].Acta Pharmaceutica Sinica B,2022,第5期 Ting Chen^1,2，Bo Zhuang^2,3，Yueqi Huang²，Yan Liu²，Bochuan Yuan²，Wanmei Wang²，Tianyu Yuan²，Lina Du^1,2，Yiguang Jin^1,2（Guangdong Pharmaceutical University；Department of Pharmaceutical Sciences，Beijing Institute of Radiation Medicine；Department of Chemical Defense，Institute of NBC Defense）.Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis[J].Acta Pharmaceutica Sinica B,2022,第5期 Zhuo-Xun Wu¹，Qiu-Xu Teng¹，Yuqi Yang¹，Nikita Acharekar¹，Jing-Quan Wang¹，Min He²，Sabesan Yoganathan¹，Jun Lin³，Jian Wang²，Zhe-Sheng Chen¹（Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John's University；Department of Radiotherapy，the Affiliated Jiangyin People's Hospital of Nantong University；Department of Anesthesiology，Stony Brook University Health Sciences Center）.MET inhibitor tepotinib antagonizes multidrug resistance mediated by ABCG2 transporter：In vitro and in vivo study[J].Acta Pharmaceutica Sinica B,2022,第5期 Zhenlu Xu¹，Dongyun Liu²，Dong Liu²，Xue Ren³，Haibo Liu¹，Guihong Qi¹，Yue Zhou¹，Chongming Wu¹，Kui Zhu⁴，Zhongmei Zou¹，Jing Yuan³，Wenhan Lin²，Peng Guo^1,3（Pharmacology and Toxicology Research Center，Institute of Medicinal Plant Development，Chinese Academy of Medical Sciences，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，Peking University；Capital Institute of Pediatrics；National Center for Veterinary Drug Safety Evaluation，College of Veterinary Medicine，China Agricultural University）.Equisetin is an anti-obesity candidate through targeting 11β-HSD1[J].Acta Pharmaceutica Sinica B,2022,第5期 Wei Shi^1,2,3，Wanzhen Li⁴，Jianxin Zhang⁴，Tiehai Li¹，Yakai Song¹，Yue Zeng¹，Qian Dong¹，Zeng Lin¹，Likun Gong¹，Shuquan Fan⁵，Feng Tang^1,2，Wei Huang^1,2,3,4（CAS Key Laboratory of Receptor Research，CAS Center for Excellence in Molecular Cell Science，Center for Biotherapeutics Discovery Research，Shanghai Institute of Materia Medica Chinese Academy of Sciences；School of Pharmaceutical Science and Technology，Hangzhou Institute of Advanced Study；University of Chinese Academy of Sciences；School of Chinese Materia Medica，Nanjing University of Chinese Medicine；School of Life Science，Liaocheng University）.One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates[J].Acta Pharmaceutica Sinica B,2022,第5期 Gan Wang¹，Min Zhang^1,2，Ping Meng¹，Chengbo Long^1,2，Xiaodong Luo³，Xingwei Yang³，Yunfei Wang^1,4，Zhiye Zhang¹，James Mwangi^1,2,5，Peter Muiruri Kamau^1,2,5，Zhi Daic¹，Zunfu Ke⁶，Yi Zhang⁷，Wenlin Chen⁸，Xudong Zhao¹，Fei Ge⁹，Qiumin Lv^1,5，Mingqiang Rong^1,5，Dongsheng Li¹，Yang Jin¹⁰，Xia Sheng¹¹，Ren Lai^1,4,5,12（Key Laboratory of Animal Models and Human Disease Mechanisms，Chinese Academy of Sciences/Key Laboratory of Bioactive Peptides of Yunnan Province，KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases，National Resource Center for Non-Human Primates，Kunming Primate Research Center，and National Research Facility for Phenotypic & Genetic Analysis of Model Animals(Primate Facility)，Kunming Institute of Zoology；University of Chinese Academy of Sciences；State Key Laboratory of Phytochemistry and Plant Resources in West China，Kunming Institute of Botany，Chinese Academy of Sciences；Institutes for Drug Discovery and Development，Chinese Academy of Sciences；Sino-African Joint Research Center，Chinese Academy of Science；Department of Pathology，First Affiliated Hospital，Sun Yat-sen University；Department of Orthopaedic Surgery，First Affiliated Hospital of Zhengzhou University；Department of Breast Surgery，Third Affiliated Hospital of Kunming Medical University，Yunnan Cancer Center；Department of Breast Surgery，First Affiliated Hospital of Kunming Medical University；Department of Biosciences，University of Oslo；Key Laboratory of Environment and Health，Ministry of Education & Ministry of Environmental Protection，And State Key Laboratory of Environmental Health，School of Public Health，Tongji Medical College，Huazhong University of Science and Technology；Center for Biosafety Mega-Science，Chinese Academy of Sciences）.Anticarin-β shows a promising antiosteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis[J].Acta Pharmaceutica Sinica B,2022,第5期 Weimin Yu^1,2，Gang Xu^3,4，Hui Chen¹，Li Xiao¹，Gang Liu^1,5，Pingping Hu¹，Siqi Li¹，Vivi Kasim⁶，Chunyu Zeng⁷，Xiaoyong Tong¹（School of Pharmaceutical Sciences，Chongqing University；Institute of Health Biological Chemical Medication，Chongqing Institute of Green and Intelligent Technology，Chinese Academy of Sciences；Institute of Medicine and Equipment for High Altitude Region，College of High Altitude Military Medicine，Army Medical University(Third Military Medical University)；Key Laboratory of High Altitude Medicine，People's Liberation Army；Henan Key Laboratory of Medical Tissue Regeneration，College of Basic Medical Sciences，Xinxiang Medical University；Key Laboratory of Biorheological Science and Technology，Ministry of Education，College of Bioengineering，Chongqing University；Department of Cardiology，Daping Hospital，Army Medical University(Third Military Medical University)）.The substitution of SERCA2 redox cysteine 674 promotes pulmonary vascular remodeling by activating IRE1α/XBP1s pathway[J].Acta Pharmaceutica Sinica B,2022,第5期 Wei Gao¹，Hongxiang Hu¹，Lipeng Dai¹，Miao He¹，Hebao Yuan¹，Huixia Zhang¹，Jinhui Liao¹，Bo Wen¹，Yan Li²，Maria Palmisano²，Mohamed Dit Mady Traore¹，Simon Zhou²，Duxin Sun¹（Department of Pharmaceutical Sciences，College of Pharmacy，University of Michigan；Translational Development and Clinical Pharmacology，Bristol Myers Squibb）.Structure-tissue exposure/selectivity relationship（STR） correlates with clinical efficacy/safety[J].Acta Pharmaceutica Sinica B,2022,第5期 Di Zhu^1,2，Yu Lu^1,2，Lin Gui^1,2，Wenjing Wang³，Xi Hu⁴，Su Chen⁵，Yanming Wang⁶，Yuji Wang^1,2（Department of Medicinal Chemistry，College of Pharmaceutical Sciences of Capital Medical University；Beijing Area Major Laboratory of Peptide and Small Molecular Drugs，Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China，Beijing Laboratory of Biomedical Materials；Beijing Institute of Hepatology，Beijing Youan Hospital，Capital Medical University；Quantum Design China Ltd.，Universal Business Park；Laboratory of Biomaterials and Biomechanics，Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction，School of Stomatology，Capital Medical University；School of Life Sciences，Henan University）.Self-assembling, pH-responsive nanoflowers for inhibiting PAD4 and neutrophil extracellular trap formation and improving the tumor immune microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期 Dong Liang，Chen Yu，Zhao Ma，Xingye Yang，Zhenzhen Li，Xuhui Dong，Xiaojun Qin，Lupei Du，Minyong Li（Key Laboratory of Chemical Biology （MOE），School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning[J].Acta Pharmaceutica Sinica B,2022,第5期 Nazi Song¹，Hongjiao Xu¹，Jiahua Liu^2,3,4，Qian Zhao¹，Hui Chen¹，Zhibin Yan^5,6，Runling Yang^5,6，Zhiteng Luo¹，Qi Liu⁷，Jianmei Ouyang⁷，Shuohan Wu¹，Suijia Luo⁷，Shuyin Ye⁷，Runfeng Lin¹，Xi Sun^2,3,4，Junqiu Xie^5,6，Tian Lan⁸，Zhongdao Wu^2,3,4，Rui Wang^5,6，Xianxing Jiang¹（School of Pharmaceutical Sciences，Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery，Sun Yat-sen University；Department of Parasitology of Zhongshan School of Medicine，Sun Yat-sen University；Key Laboratory of Tropical Disease Control，Ministry of Education，Sun Yat-sen University；Provincial Engineering Technology Research Center for Biological Vector Control，Sun Yat-sen University；Research Unit of Peptide Science，Chinese Academy of Medical Sciences；Key Laboratory of Preclinical Study for New Drugs of Gansu Province，School of Basic Medical Sciences，Lanzhou University；Shenzhen Turier Biotech.Co.，Ltd.；Guangdong Pharmaceutical University）.Design of a highly potent GLP-1R and GCGR dual-agonist for recovering hepatic fibrosis[J].Acta Pharmaceutica Sinica B,2022,第5期 Peihua Liu¹，Ling Jiang¹，Weimin Kong¹，Qiushi Xie¹，Ping Li¹，Xiaonan Liu¹，Jiayi Zhang¹，Ming Liu¹，Zhongjian Wang²，Liang Zhu¹，Hanyu Yang¹，Ying Zhou¹，Jianjun Zou³，Xiaodong Liu¹，Li Liu¹（Center of Drug Metabolism and Pharmacokinetics，School of Pharmacy，China Pharmaceutical University；Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy，Xuzhou Medical University；Department of Clinical Pharmacology，Nanjing First Hospital，Nanjing Medical University）.PXR activation impairs hepatic glucose metabolism partly via inhibiting the HNF4α-GLUT2 pathway[J].Acta Pharmaceutica Sinica B,2022,第5期 Lihuan Shang¹，Xue Jiang^1,2，Ting Yang¹，Hongbo Xu¹，Qi Xie¹，Mei Hu¹，Conglian Yang¹，Li Kong¹，Zhiping Zhang^1,3,4（Tongji School of Pharmacy，Huazhong University of Science and Technology；Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation，Medical Research Center，Sun Yat-sen Memorial Hospital，Sun Yat-sen University；National Engineering Research Center for Nanomedicine，Huazhong University of Science and Technology；Hubei Engineering Research Centre for Novel Drug Delivery System，Huazhong University of Science and Technology）.Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment[J].Acta Pharmaceutica Sinica B,2022,第5期首页上一页 4 5 6 7 8 下一页尾页共有12页，转到页

期刊文章列表